Tuesday, December 31, 2019

Alkem Labs acquires anti-nausea drug Marinol from AbbVie for $10 million

Alkem Labs acquires anti-nausea drug Marinol from AbbVie for $10 million Marionol capsules are used to treat the loss of appetite (anorexia) in AIDS patients and to treat nausea and vomiting in patients receiving chemotherapy.

from Moneycontrol Business News https://ift.tt/2rGFKLI

No comments:

Post a Comment

Network18 Q4 loss at Rs 29.61 crore, revenue up 9.7% to Rs 615.78 cr

Network18 Media & Investments reported a consolidated net loss of Rs 29.61 crore for the March quarter, despite a 9.7% rise in operation...